Most biotech CEO's make presentations to investors by being invited to Brokerage and Institutional Conferences. The problem with NWBO and others trading on the OTC or Pinks, and especially those under $1 is that they almost never get invitations to such events, unless their company does something spectacular, and then it won't be trading for pennies anymore.
There may be places they can pay to appear at, it may be better than nothing, but most know it's not really a credible place. LG's appearance on the Big Biz show probably gets put down more than it's respected, but it's an example of what can be done.
I suspect that Larry Smith is hanging on for UK action, but others quick to criticize remain active in trying to knock the company down. NYAS is a prestigious conference, whether people here believe it, or not, but it's for scientists, not CEO's making presentations.
I'll be the first to admit, I'm not a subject matter expert, I listen to the opinions of others and may stir the pot a little with my ideas. AdamF, with his Poli-Sci degree, may very well attend NYAS and criticize Dr. Bosch and sadly some people think he knows what he's talking about. Those who know him know he's a tool of the shorts, but not everyone knows that. We'll see if he puts down Dr. Bosch's second generation thoughts, the way he has the first-generation product.
Gary
Bullish
Market Data 
Markets 
